As rothman urges, teaching hospitals should forbid : drug-company representatives from coming into the hospital : to promote their wares and offer gifts to students and : house officers, for instance, finasteride australia. 62.2% 135 ; 14.7% 32 ; 23.0% 50 ; 3.2% 7 ; 62.7% 136 ; 34.1% 74 ; Treatment Same dose 81.6% 177 ; Increase dose 17.0% 37 ; Add finasteride 1.4% 3. The findings insurance crisis doctors have finasteride the center remicade cues and flagyl.

Clinical efficacy is represented by results obtained during randomized clinical trials where strict controls, including adherence to dosage regimens can be monitored. In contrast, clinical effectiveness is represented by a combination of efficacy with compliance to more accurately represent real world clinical situations where monitoring may be absent. As part of the sensitivity analysis, the efficacy of finasteride was assumed to be 100%; all patients receiving finasteride had symptom improvement. The results demonstrate the apparent paradoxical, yet common sense nature of cost-effectiveness analysis. In this situation, as the efficacy of finasteride increases, the cost-effectiveness of finasteride compared to prazosin or the other alpha-blockers ; actually becomes worse. This result occurs because the cost of finasteride is greater than any possible advantage it could have in efficacy compared to prazosin. Therefore, as more patients are successfully treated first with finasteride, the total cost increases faster than the total effectiveness. Even in the face of a 100% efficacy for finasteride, it is even more costeffective to treat as many people as possible with prazosin, before switching to the hypothetically more efficacious finasteride for those patients that fail the lower cost and less efficacious prazosin. When comparing the reported cost-effectiveness ratio for prazosin in Table 4 with Table 6, a discrepancy can be noted. Although the percent of treatment success is equal in both tables, disparity arises in the two reported cost-effectiveness ratios. The discrepancy was attributed to the fact that Table 4 accounts for all patients, whereas Table 6 accounts for 99.41% who were successfully treated. If treatment failures were accounted for in Table 6, the total average cost-effectiveness would be an expected $1159.67. The $4.86 difference is rounding error. BPH Treatment Guidelines Based on the results of this study, the Pharmacoeconomic Center recommends the following treatment guidelines for mild to moderate BPH patients who have failed watchful waiting. An algorithm for the treatment of mild to moderate BPH and fluconazole.

Medicine Physicians are trained in diagnostic techniques that narrow down the range of options, relying heavily on objective data such as laboratory tests in the process. Geriatricians are embracing new models of care as we begin to move away from the traditional problem-based model of care and move toward a goal-oriented approach to geriatric care. The traditional model focusing on acute medical problems loses relevance when dealing with chronic, disabling conditions experienced by older adults. The more recent models of care focus not only on how the problem is described, but also on who controls how the problem is defined and, subsequently, treated. This new goal-oriented approach includes the following assumptions. Health benefits demonstrated with the use of sibutramine include reductions in triglycerides, uric acid, total cholesterol, ldl cholesterol and an increase in hdl cholesterol and glibenclamide. These can be helped and avoided by taking the medicines with a meal or snack.

By this mechanism, finasteride appears to interrupt a key factor in the development of androgenetic alopecia in those patients genetically predisposed and glucovance.

Finasteride what is More about: finasteride finasteride improves the sensitivity of digital rectal examination for pros : 00 n the may, 2007 issue of the journal of urology, dr. Health sections: home healthy living diseases & conditions health news groups & boards drug guide site index aging alternative medicine beauty birth control caregiving first aid & safety fitness nutrition & food oral care parenting pregnancy relationships smoking cessation stress travel health weight loss work issues adhd & add allergy arthritis asthma breast cancer cancer & chemotherapy children's health cholesterol cold & flu colon cancer depression diabetes digestive health headache & migraine heart & vascular health heartburn & gerd high blood pressure hiv & aids men's health mental health multiple sclerosis obesity osteoporosis sexual health & stds skin conditions sleep disorders stroke women's health » more topics drug guide provided by: healthwise a a-ag ah-ap aq-az b b-bg bh-bp bq-bz c c-cg ch-cp cq-cz d d-dg dh-dp dq-dz e e-eg eh-ep eq-ez f f-fg fh-fp fq-fz g g-gg gh-gp gq-gz h h-hg hh-hp hq-hz i i-ig ih-ip iq-iz j j-jg jh-jp jq-jz k k-kg kh-kp kq-kz l l-lg lh-lp lq-lz m m-mg mh-mp mq-mz n n-ng nh-np nq-nz o o-og oh-op oq-oz p p-pg ph-pp pq-pz q q-qg qh-qp qq-qz r r-rg rh-rp rq-rz s s-sg sh-sp sq-sz t t-tg th-tp tq-tz u u-ug uh-up uq-uz v v-vg vh-vp vq-vz w w-wg wh-wp wq-wz x x-xg xh-xp xq-xz y y-yg yh-yp yq-yz z z-zg zh-zp zq-zz 0-9 0-2 3-6 7-9 finasteride pronunciation: fih nah steh ride brand names: propecia, proscar drug details what is the most important information i should know about finasteride and inderal. Rat peritoneal mast cells [207] and serotonin release from porcine small intestine [208] through H3-receptors. H3-receptor agonists were also shown to inhibit brain mast cells [209] and it was further shown that their inhibitory effect may be through their action on sensory nerve endings found in close contact with mast cells [210]. The possible therapeutic significance of H 3 -receptor agonists has been reviewed recently [211]. It is important to note that the new H3-receptor agonist prodrug BP-2-94 has shown analgesic and anti-inflammatory properties [212]. With respect to IC, this agent reduced cyclophosphamide-induced cystitis in mice and significantly decreased leukocyte infiltration and protein extravasation in the urinary bladder [212], for example, finasteride review.

Cost of Finasteride Both proscar and propecia are brand names of a finasteride based tablet and itraconazole. Home articles health topics diseases & conditions tests & procedures drugs & supplements symptoms site map quick links impotence impotence treatment peyronie' s propecia finasteride tadalafil sildenafil citrate vardenafil tamsulosin what is dutasteride used for. Acetazolamide Diamox ; 250mg tab; 500mg SR cap Acetylcysteine Mucomyst ; 10% & 20% inh soln Acitretin Soriatane ; 10 & 25mg capsule Aminobenzoate Potaba ; 500mg capsule Aminocaproic Acid Amicar ; 500mg tablet Cabergoline Dostinex ; 0.5mg tablet Desmopressin rhinal tube; spray; 0.1 & 0.2mg tab Disulfiram Antabuse ; 250mg tablet Epinephrine Epipen -Jr ; 0.15 & 0.3mg syringe Etidronate Didronel ; 200 & 400mg tablet Finast4ride Proscar ; 5mg tablet Ipecac Syrup Leucovorin 5 & 25mg tablet Levocarnitine Carnitor ; 330mg tab; 100mg ml liq Methazolamide Neptazane ; 50mg tablet and kamagra.

With finasteride use, although dht levels go down, testosterone levels go up ( as the testosterone is no longer being converted to dht, it has to be metabolized via other pathways).
Doxazosin Fimasteride -0.015 -.031, .001 .000, .009 1 0 285 0.063 .015, Terazosin Finasterids and ketoconazole and finasteride.

It is how finasteride works that enthuses doctors familiar with the drug.

Compared with finasteride, repens produces similar improvements in urinary tract symptoms and flow measures, has fewer adverse treatment effects, and costs less and lamisil.
Atkinson RM, Davis B, Pratt MA, Sharpe HM and Tomich EG 1965 ; Action of some steroids on the central nervous system of the mouse. II. Pharmacology. J Med Chem 8: 426 432. Azzolina B, Ellsworth K, Andersson S, Geissler W, Bull HG and Harris GS 1997 ; Inhibition of rat -reductases by finasteride: Evidence for isozyme differences in the mechanism of inhibition. J Steroid Biochem Mol Biol 61: 55 64. Barnea A, Hajibeigi A, Trant JM and Mason JI 1990 ; Expression of steroid metabolizing enzymes by aggregating fetal brain cells in culture: A model for developmental regulation of the progesterone 5 -reductase pathway. Endocrinology 127: 500 502. Belelli D, Bolger MB and Gee KW 1989 ; Anticonvulsant profile of the progesterone metabolite 5 -pregnan-3 -ol-20-one. Eur J Pharmacol 166: 325329. Bitran D, Hilvers RJ and Kellogg CK 1991 ; Anxiolytic effects of 3 -hydroxy-5 ; pregnan-20-one: Endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Res 561: 157161. Bitran D, Shiekh M and McLeod M 1995 ; Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors. J Neuroendocrinol 7: 171177. Celotti F, Negri-Cesi P and Poletti A 1997 ; Steroid metabolism in the mammalian brain: 5 -Reduction and aromatization. Brain Res Bull 44: 365375. Conney AH, Jacobson M, Levin W, Schneidman K and Kuntzman R 1966 ; Decreased central depressant effect of progesterone and other steroids in rats pretreated with drugs and insecticides. J Pharmacol Exp Ther 154: 310 318. Craig CR 1966 ; Anticonvulsant activity of steroids: Separability of anticonvulsant from hormonal effects. J Pharmacol Exp Ther 153: 337343. Gee KW, Bolger MB, Brinton RE, Coirini H and McEwen BS 1988 ; Steroid modulation of the chloride ionophore in rat brain: Structure-activity requirements, regional dependence and mechanism of action. J Pharmacol Exp Ther 246: 803 812 Gee KW, McCauely LD and Lan NC 1995 ; A putative receptor for neurosteroids on the GABAA receptor complex: the pharmacological properties and therapeutic potential of epalons. Crit Rev Neurobiol 9: 207227. Gyermek L, Genther G and Fleming N 1967 ; Some effects of progesterone and related steroids on the central nervous system. Int J Neuropharmacol 6: 191198. Gyermek L, Iriarte J and Crabbe P 1968 ; Steroids. CCCX. Structure-activity relationships of some steroidal hypnotic agents. J Med Chem 11: 117125. Harrison NL, Majewska MD, Harrington JW and Barker JL 1987 ; Structureactivity relationships for steroid interactions with the -aminobutyric acidA receptor complex. J Pharmacol Exp Ther 241: 346 353. Herzog AG 1995 ; Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology 45: 1660 1662. Kokate TG, Svensson BE and Rogawski MA 1994 ; Anticonvulsant activity of neurosteroids: Correlation with -aminobutyric acid-evoked chloride current potentiation. J Pharmacol Exp Ther 270: 12231229. Kondo KH, Kai MH, Setoguchi Y, Eggertsen G, Sjoblom P, Setoguchi T, Okuda KI and Bjorkem I 1994 ; Cloning and expression of cDNA of human , 4-3-oxosteroid 5 -reductase and substrate specificity of the expressed enzyme. Eur J Biochem 219: 357363. Korneyev A and Costa E 1996 ; Allopregnanolone THP ; mediates anesthetic effects of progesterone in rat brain. Horm Behav 30: 37 43. Kraulis I, Foldes G, Traikov H, Dubrovsky B and Birmingham MK 1975 ; Distribu. Proper closure true figure eight sutures and two layers of closure whenever necessary ; are of paramount importance in minimizing postoperative adhesion formation. To reduce the associated blood loss, surrounding muscles may be infiltrated with a dilute solution of vasopressin 20 IU in saline ; . Compression of the uterine arteries via application of a tourniquet through the broad ligaments, in our experience, is unnecessary and may result in unwanted complications. Myolysis: The methods of myolysis--using either bipolar electric needles, lasers, or cryotherapy-- have had various results.46-48 These procedures destroy fibroids and obliterate their blood supply, leading to shrinkage of fibroid size by 50%. An advantage of cryotherapy is that it does not contribute to mutagen formation. Long-term safety and efficacy of these procedures have not been established. RADIOLOGIC APPROACH Uterine artery embolization is emerging as a new nonsurgical treatment of uterine fibroids.49-51 The procedure involves the injection of plastic particles under fluoroscopic visualization to occlude the fibroid vessels. The size of the particles varies from 500 to 900 microns. The particles are injected into the uterine arteries following catheterization via the femoral artery. After embolization, fibroid size may be reduced by up to 60%. Most patients will experience improvement in symptoms, especially amelioration of heavy menstrual flow. Although subsequent pregnancies have been reported after uterine artery embolization, in general the procedure is not advised in those patients who desire to preserve fertility. The most common adverse effect is postprocedure pain. The pain is usually self-limited and responds to NSAIDs. It is thought to be due to the fibroid necrosis that follows embolization. Another reported complication is postembolization syndrome pain, fever, leukocytosis, and nausea ; , which may require bed rest, antibiotics, and analgesics. Other potential complications include fatal septicemia, fatal pulmonary embolism, hemorrhage, endometritis pyometritis, pseudoaneurysm, prolapsed fibroid, contrast-related renal failure, hematoma, and inadvertent embolization of other vessels, with its adverse effects ie, bladder necrosis ; .52-59 Premature ovarian failure has been reported; it is believed to result from the radiation exposure, which is usually equal to that of two barium enemas. In general, uterine artery embolization should be limited to a select group of patients who have a limited number of fibroids that are not larger than 5 cm in diameter. Furthermore, the procedure must always be performed by a qualified radiologist. Advantages of uterine artery embolization are avoidance of surgery and shorter hospitalization and recovery time. The disadvanVol. 5, No. 10 OCTOBER 2002. Missed dose if you miss a dose of finatseride and you remember the same day, take it as soon as possible. Compare proscar finadteride 5mg 90 tablets prices - shop for. Avodart or finasterid4 both avodart and finasteride are available to treat an enlarged prostate and flagyl. Ontario Provincial Advanced Care Medical Directives Pre-Hospital Treatment Of Unstable Tachycardia Kingston Base Hospital ; Standing Order When the following indications and conditions exist, the Advanced Care Paramedic should treat the patient according to the following protocol, without establishing Base Hospital Physician contact. Indications 1. Patient presents with a tachyarrhythmia other than sinus tachycardia ; at a rate 150 narrow complex ; or 120 wide complex ; BPM AND 2. Patient is clinically unstable secondary to tachycardia significant chest pain, severe SOB, decreased LOC, hypotension SBP 100 mmHg ; , pulmonary edema, suspected acute MI ; . Conditions 1. Patient 40 kg. PROCEDURE 1. O2 non-rebreather 10 Lpm. Support airway as necessary if reduced level of consciousness by use of BVM or endotracheal intubation. 2. Cardiac monitor consider acquisition of 12 lead to confirm rhythm ; 3. Vital signs, including continuous SpO2 monitoring. 4. Establish IV access. 5. Consider sedation analgesia according to standing order. Final Version April 2007 38.

I 3-64 years old mean, 35.7 years; median, 28.5 years ; . patients had duodenal ulcer disease. All three had normal gastrin levels. Three patients had Zollinger-Ellison syndrome Three serum table. Objective: To review the role of human papillomavirus HPV ; infection as a potential cause of human cancers. Method: Literature review. Results: HPVs are DNA viruses with an approximately 8000 base-pair genome size. There are more than 100 HPV types, of which about 40 infect the anogenital and upper. Deborah, australia propecia proscar finasteride ; and pregnancy below will help you to determine if your exposure to propecia proscar finasteride ; during what are propecia and proscar.
Of Health and Bioscience, University of East London, London, UK, 2Institute of Neurology, UCL, London, UK and 3Centre for Neuromuscular and Neurological Disorders, UWA, Perth, WA, Australia It is well known that when pairs of transcranial magnetic stimulation TMS ; pulses are applied to the motor cortex, the corresponding motor evoked potential MEP ; responses are altered compared to those of single pulses. At appropriate interstimulus intervals ISIs ; paired pulses are facilitatory, and this is believed to result from summation of I-waves by the secondary TM stimulus Ziemann et al. 1998 ; . If this is the case it should be possible to further enhance MEP responses by delivering additional stimuli at I-wave periodicity in order to target later I-waves. Therefore we have compared double pulse TMS responses with those of triple pulse TMS tTMS ; at varying ISIs. In seven healthy subjects 30-45 years ; TMS was delivered to the optimal scalp position for MEP responses from the dominant first dorsal interosseus muscle using a 9cm diameter figure-8 coil held tangentially to the skull. Resting RMT ; and active motor thresholds AMT ; to single pulse TMS Magstim 200 ; were determined for each subject and subsequent double and tTMS 3 x Magstim 200 units connected to a single coil ; were delivered in the resting condition at an intensity equivalent to AMT. Double pulses condition A ; were delivered at an ISI of 1.5ms, whilst the 3 tTMS conditions comprised ISIs between stimuli 1-2 and 2-3 of 1.5 1.5ms B 1.5 2.0ms C ; and 1.5 3.0ms D ; , respectively. Ten tTMS stimuli for each condition were delivered pseudo-randomly with 5 s intervals between each stimulation. Repeated measures ANOVA was used to determine the effects of condition and ttests were performed post-hoc using Bonferroni correction as appropriate. Values are mean SEM and the overall level of significance is p 0.05. No MEPs were elicited using single pulse TMS at the stimulus intensity used since the muscle was non-active and RMTs were approximately 10% higher than AMTs ; . The double pulse condition resulted in discernable MEPs in all subjects condition A 0.81 0.19 mV ; . Triple pulses at the same intensity resulted in larger MEPs and these differences were significant for conditions B 2.33 0.32 mV; p 0.002 ; and D 1.48 0.36 mV; p 0.01 ; , but not condition C 0.97 0.16 mV; p 0.05 ; . Comparing triple pulses, condition B with the shortest S2-S3 ISI elicited significantly larger responses than the conditions with longer S2-S3 intervals condition C; p 0.01 and condition D; p 0.05 ; . Conditions C and D were not significantly different from each other. We conclude that triple pulse TMS has a powerful facilitatory effect on MEP production under resting conditions and is highly dependent on the interpulse intervals. These results are consistent with the hypothesis that multiple TMS pulses can be used to target the properties of the cortical circuitry involved in the generation of I-waves, for example, finasteride hair loss.

Side effects of Finasteride Medication safety issues sound-alike look-alike issues: doxazosin may be confused with doxapram, doxepin, doxorubicin cardura® may be confused with cardene® , cordarone® , cordran® , coumadin® , k-dur® , ridaura® pronunciation doks ay zoe sin ; brand names cardura® xl cardura® index terms doxazosin mesylate generic available yes: excludes extended release tablet canadian brand names alti-doxazosin apo-doxazosin® cardura-1™ cardura-2™ cardura-4™ gen-doxazosin novo-doxazosin pharmacologic category alpha1 blocker pharmacologic category synonyms adrenergic antagonist, alpha 1 use treatment of hypertension alone or in conjunction with diuretics, ace inhibitors, beta-blockers, or calcium antagonists; treatment of urinary outflow obstruction and or obstructive and irritative symptoms associated with benign prostatic hyperplasia bph ; , particularly useful in patients with troublesome symptoms who are unable or unwilling to undergo invasive procedures, but who require rapid symptomatic relief; can be used in combination with finasteride use: unlabeled investigational pediatric hypertension pregnancy risk factor c pregnancy implications some studies demonstrated embryolethality resulting from doxazosin exposure during organogenesis. Side effects of Finasteride Proves urinary tract symptoms and urinary tract flow measures. Compared with placebo, S repens improved urinary tract symptoms by 28%, nocturia by 25%, peak urine flow by 24%, mean urine flow by 28%, and residual urine volume by 43%. Men taking S repens were nearly twice as likely to report improvement in symptoms than men taking placebo. When compared with finasteride, S repens provided similar responses in urologic symptoms and flow measures and was associated with a lower rate of erectile dysfunction. Participant baseline characteristics regarding age, prostate volume, peak urine flow, and symptom scale scores were comparable with previous trials and meta-analyses involving pharmaco1607. 1. 2. 3. Does the patient have a diagnosis of Alzheimer's type dementia? Yes No The Alzheimer's dementia can be classified as Check One ; : Mild Moderate Severe Has the patient been on the drug being requested for the previous 6 months? Yes No Has the patient been evaluated with the Mini-Mental State Exam MMSE ; for cognitive status assessment for No cognitive status assessment within the previous 3-6 months? Yes Has the rate of cognitive status deterioration further declined since initial treatment or since the Mini-Mental State Exam? Yes No. Finasteride price 16. Bloch E, Lew M, Klein M. 1971. Studies on the inhibition of fetal androgen formation: Inhibition of testosterone synthesis in rat and rabbit fetal testes with observations on reproductive tract development. Endocrinology 89: 16-31. 17. Goldman AS. 1971 ; . Production of hypospadias in the rat by selective inhibition of fetal testicular 17-hydroxylase and C17-26-lyase. Endocrinology 88: 527-531. 18. Goldman AS, Eavey RD, Baker MK. 1976 ; . Production of male pseudohermaphroditism in rats by two new inhibitors of steroid 17-hydroxylase and C17-26-lyase. J. Endocrinol. 71: 289-297. 19. Imperato-McGinley, J., Binieda, Z., Arthur A, Miniberg DT, Vaughan ED, Jr, Quimby FW. 1985 ; . The development of a male pseudohermaphrodite rats using an inhibitor of the enzyme 5-reductase. Endocrinology 116: 807-812. 20. Imperato-McGinley J, Sanchez RS, Spencer JR, Yee B, Vaughan ED. 1992 ; . Comparison of the effects of 5-reductase inhibitor F9nasteride and the antiandrogen Flutamide on prostate and genital differentiation: Dose-response studies. Endocrinology 131: 1149-1156. 21. Cunha GR, Cooke PS, Bigsby R, Brody JR. 1992. Ontogeny of sex steroid receptors in mammals. In: Nuclear hormone receptors. Molecular mechanisms, cellular functions, clinical abnormalities. Parker, MG, ed. Academic Press, pp235-268. 22. Imperato-McGinley J, Peterson RE. 1976 ; . Male pseudohermaphoroditism: The complexities of male phenotypic development. Am. J. Med. 61: 251-272. 23. Peterson RE, Imperato-McGinley J, Gautier T, Stural E. 1977 ; . Male pseudoherma-phrodism due to steroid 5-reductase deficiency. Am. J. Med. 62: 170-191. 24. Wilson JD, Griffin JE, Russell DW. 1993 ; . Steroid 5-reductase deficiency. Endocr. Rev. 14: 577593. 25. Yeh SY, Tsai MY, Xu QQ, Mu XM, Lardy H, Huang KE, Lin H, Yeh SD, Altuwaijri S, Zhou XC, Xing LP, Boyce BF, Hung MC, Zhang S, Gan L, Chang CS. 2002 ; . Generation and characterization of androgen receptor knockout ARKO ; mice: An in vivo model for the study of androgen functions in selective tissues PNAS 99: 13498-13503. 26. Sato T, Kawano H, Kato S. 2002 ; . Study of androgen action in bone by analysis of androgen-receptor deficient mice. J. Bone Min. Metab. 20: 326-330 27. Callow RK, Deanesly R. 1935 ; . Effect of androsterone and of male hormone concentrate on the accessory reproductive organs of castrated rats, mice and guinea-pigs. Biochem. J. 29: 1424-1445. 28. Korenchevsky V. 1932 ; . The assay of testicular hormone preparations. Biochem. J. 26: 413-422. 29. Korenchevsky V, Dennison M, Schalit R. 1932 ; . The response of castrated male rats to the injection of the testicular hormone. Biochem. J. 26: 1306-1314. 31. Eisenberg E, Gordan GS. 1950 ; . The levator ani muscle of the rat as an index of myotrophic activity of steroidal hormones. J. Pharmacol. Exp. Therap. 99: 38-44. 32. Eisenberg E, Gordan GS, Elliott HW. 1949 ; . Testosterone and tissue respiration of the castrate male rat with a possible test for mytrophic activity. Endocrincology 45: 113-119. 33. Hershberger L, Shipley E, Meyer R. 1953 ; . Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle method. Proc Soc Exp Biol Med. 83: 175-180. 34. Peets EA, Henson MF, Neri R. 1973 ; . On the mechanism of the antiandrogenic action of flutamide ; in the rat. Endocrinology 94: 532-540. Basically, the following chart shows the baseline level of lh in male sheep given a 5-alpha-reductase inhibitor finasteride ; , then a chart showing the lh levels in sheep given testosterone propionate, and finally a chart showing lh levels of sheep given testosterone propionate + the inhibitor graph 3 in the series ; 2. Two small studies have found that after combination therapy with an alpha1-blocker and finasteride, most men were able to discontinue the alpha 1 -blocker without a worsening of symptoms if they had been maintained on dual therapy for at least 9-12 months b1. 1. Mani M.K. Prevention of chronic renal failure at community level. Kidney Int. suppl 2003 83 ; , S86 89. 2. Parving HH. Prevalence and cause of Albuminuria in NIDDM. Kidney Int. 1992 41 4 ; : 758 62 3. John L, Sundar Rao PSS, Kanagasabapathy AS. Prevalence of diabetic nephropathy in non-insulin dependent diabetics. Indian J Med Res. 1991; 94: 2429. Viswanathan M, Snehalatha C, Bhattacharyya PK, Mohan V, Ramachandran A. Microalbuminuria in NIDDM patients in South India. Indian J. Med. Res. B ; 1991; 94: 125-9. Gupta LK, Varma LK, Khosla PK, Dash SC. The prevalence of microalbuminuria in Indian diabetes, Indian J. Nephrol 1991; 1: 61. Chugh KS, Kumar R, Sakhuja V, Pereira BJ, Gupta A. Nephropathy in type 2 diabetes mellitus in Third World Countries. Chandigarh Study. Int. J. Artif. Organs 1989; 12: 299. Acharya VN, Chawla KP. Diabetic Nephropathy. A review journal of post-graduate medicine. 1978; 24 3 ; : 138 146. 8. Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease with emphasis on the stage of incipient diabetic nephropathy. Diabetes 1983; 28: 6 Uusitupa M, Siitonen O, Penttila I, Aro A, Pyorala K. Proteinuria in Newly Diagnosed Type II Diabetic Patients. Diabetes Care, 1987, 2, 191-194. Ballard DJ, Humphrey LL, Melton LJ III, Frohnert PP, Chu C-P, O'Fallon WM, Palumbo PJ. Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota. Diabetes, 1988, 37, 405- Ravid M, Savin H, Jutrin I, Bental T, Kaiz B, Lishner M: Long term stabilizing effect of angiotensin converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med, 1993, 118, 577-581. Schmitz A, Vaeth M, Mogensen CE. Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM. Diabetologia, 1994, 37, 1251 Viswanathan V, Snehalatha C, Terin Mathai, Muthu Jayaraman, Ramachandran A. Cardiovascular morbidity in proteinuric South Indian NIDDM patients. Diabetes Res Clin Pract 1998; 39: 63 - 67. 14. Vijay Viswanathan, C Snehalatha, B M Nair, A Ramachandran. Validation of a method to determine albumin excretion rate in type 2 diabetes mellitus. The Indian Journal of Nephrology, Vol. 13, 2003, Pg: 85-88. 15. Vijay Viswanathan, Snehalatha Chamukuttan, Shina Kuniyil, Ramachandran Ambady. Evaluation of a simple, random urine test for prospective analyses of proteinuria in Type 2 diabetes: a six year follow-up study. Diabetes Research and Clinical Practice. 2000; 49: 143-147. Vijay V, Seena R, Lalitha S, Snehalatha C, Muthu J, Ramachandran A. Significance of Microalbuminuria at diagnosis of type 2 diabetes. Diabetes Bulletin, International Journal of Diabetes in Developing countries 1998; 18: 5-6 Vijay V, Snehalatha C, Shina K, Lalitha S, Ramachandran A. Familial aggregation of diabetic kidney disease in Type 2 diabetes in South India. Diabetes Research and Clinical Practice, 1999; 43: 167-171. UK Prospective Diabetes Study Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes: UKPDS 33. Lancet 1998; 352: 837. Information accessed through jacksonville medical park is not exhaustive and does not cover all diseases, ailments, physical conditions or their treatments.